It was remarkable that in the few mice with residual pancreatic cancer tumors, studies of those tumors revealed marked suppression of PDX-1 and marked enhancement of both P53 and apoptosis 90 days after therapy. This evidence concerns the gene TP53 and pancreatic neoplasm.